| OBSERVATION'S | Co. s main drug discovery technology is its solid-phase synthesis technique for conducting combi. chemistry. The Co. s collection of 7.5 million druglike compds is one of the world s largest & acts as a starting point for its subsequent ultra-HT screening & optimization services. The technology synthesizes compds on the microgram scale, so Partner s services come in when a customer wants larger quantities of a particular compd or a library of compds around an active molecule. We will start with our expertise in medicinal chemistry & molecular modeling. Co. has already created 3 semiexclusive compd libraries with Partner, & a 4th is in the works |
|
Want more information ? Interested in the hidden information ? Click here and do your request. |